THC Form 144: Holder plans sale of 11,756 Tenet Healthcare shares

Rhea-AI Filing Summary

Tenet Healthcare (THC): Form 144 notice of proposed sale

A holder of Tenet Healthcare common stock filed a Form 144 to sell up to 11,756 shares of common stock, with an aggregate market value of $2,399,032.11. The proposed sale is noted for 11/04/2025 on the NYSE through Fidelity Brokerage Services LLC.

Tenet Healthcare had 87,885,000 shares outstanding. The shares to be sold were acquired via restricted stock vesting in two tranches: 939 shares on 05/04/2021 and 10,817 shares on 05/03/2022. In the past three months, a sale of 15,099 shares on 11/03/2025 generated gross proceeds of $3,031,952.87.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	11756	2399032.11	87885000	11/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/04/2021	Restricted Stock Vesting	Issuer			939	05/04/2021	Compensation
Common	05/03/2022	Restricted Stock Vesting	Issuer			10817	05/03/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Tammy N. Romo 14201 Dallas Parkway Dallas TX 75254	Common	11/03/2025	15099	3031952.87

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Tenet Healthcare (THC) disclose in this Form 144?

A notice to sell up to 11,756 shares of Tenet Healthcare common stock, valued at $2,399,032.11 in aggregate.

When is the proposed sale date for the THC shares?

The filing lists an approximate sale date of 11/04/2025.

Which broker and exchange are named for the THC share sale?

The sale is through Fidelity Brokerage Services LLC on the NYSE.

How many Tenet Healthcare shares are outstanding?

Shares outstanding were 87,885,000.

How were the Form 144 shares acquired?

By restricted stock vesting: 939 shares on 05/04/2021 and 10,817 shares on 05/03/2022.

Were there recent sales by the same person in the last three months?

Yes. A sale of 15,099 shares on 11/03/2025 generated $3,031,952.87 in gross proceeds.